Development and Evaluation of 'My Voice': A Randomized Controlled Trial
1 other identifier
interventional
244
1 country
1
Brief Summary
The study aims to develop and evaluate a web-based interactive platform (called 'My Voice') that helps to educate patients with heart failure and their caregivers about heart failure, identify their goals for end-of-life care, and share these with their caregivers and doctors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 13, 2023
CompletedFirst Posted
Study publicly available on registry
October 19, 2023
CompletedStudy Start
First participant enrolled
March 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
April 21, 2026
April 1, 2026
3 years
October 13, 2023
April 16, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Proportion of patients who have ACP discussions with their treating doctor at least once during the study period
will be assessed from medical records and survey
1 year from data collection
Proportion of patients who have ACP discussions with their caregivers
will be assessed from the survey
1 year from data collection
Proportion of patients who prefer life-extending treatments
will be assessed from the survey
1 year from data collection
Secondary Outcomes (3)
Proportion of patients with psychological distress
1 year from data collection
Peace and acceptance scores
1 year from data collection
Proportion of patients having decision maker
1 year from data collection
Study Arms (2)
My Voice
EXPERIMENTALIntervention arm patients will complete the patient version of 'My Voice' at least once every 3 months for 1 year or until they pass away (whichever is earlier). Caregivers of patients in the intervention arm will complete the caregiver version of 'My Voice' at least once every 3 months for 1 year (or until the patient passes away, whichever is earlier).
Control
NO INTERVENTIONControl arm patients and caregivers will receive usual care.
Interventions
The web intervention educates patients about their illness and supports them to make their own Advance Care Planning decisions, update these decisions frequently as their clinical condition changes, and to make the ACP process easier and more accessible. The intervention aims to shift implementation of ACP from a provider-led one-time model to a patient-led dynamic model.
Eligibility Criteria
You may qualify if:
- Age ≥ 21 years old
- Singaporean or Permanent Resident
- Diagnosed with heart failure
- Symptoms classified under NYHA class II (with an ejection fraction of less than or equal to 35%), III or IV
- Intact cognition determined through the Abbreviated Mental Test (AMT) (for pilot testing and main RCT)
- Ability to speak and read English, Mandarin or Malay
- Willing to complete a web intervention
- Easily contactable via mobile phone or landline
- Have a permanent address in Singapore for at least the next 1 year
- Not recruited in a previous phase of the study
- Age ≥ 21 years old
- Nominated as a healthcare spokesperson by the patient or the main decision maker for the patient (for intervention arm only)
- Ability to speak and read English, Mandarin or Malay
- Willing to complete a web intervention
- Easily contactable via mobile phone or landline
- +1 more criteria
You may not qualify if:
- a) domestic helper
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke-NUS Graduate Medical Schoollead
- Changi General Hospitalcollaborator
- Singapore General Hospitalcollaborator
- Sengkang General Hospitalcollaborator
- National Heart Centre Singaporecollaborator
- Khoo Teck Puat Hospitalcollaborator
Study Sites (1)
Duke-NUS
Singapore, Singapore, 169857, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chetna Malhotra
Duke-NUS Graduate Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 13, 2023
First Posted
October 19, 2023
Study Start
March 7, 2024
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share